Supply/Disclosures
Printed by:
Supply:
Healio Interviews
Disclosures:
Leffert, Safer and Tangpricha report no related monetary disclosures.
SAN DIEGO — On this video unique, Jonathan D. Leffert, MD, talks with Joshua D. Safer, MD, FACP, FACE, and Vin Tangpricha, MD, PhD about scientific and political challenges in caring for transgender sufferers.
Leffert is managing companion at North Texas Endocrine Heart and previous president of AACE. He’s additionally an Endocrine At the moment Editorial Board Member. Safer is an Endocrine At the moment Editorial Board Member, who’s govt director of the Heart for Transgender Medication and Surgical procedure at Mount Sinai Health System and professor of medication on the Icahn Faculty of Medication at Mount Sinai. Tangpricha is professor of medication within the division of endocrinology, metabolism and lipids at Emory College Faculty of Medication.
“We as endocrinologists ought to be extra snug [caring for this patient population],” Safer stated. “That is an space the place we have already got power. Different gaps are within the realm of the proof base for a few of our decisions, and that once more is a job for us as endocrinologists on this area to paved the way.”
American Affiliation of Medical Endocrinology Annual Assembly
Discussion about this post